MET amplification [26], PIK3CA mutations and amplification [7, 10, 11, 26], ERBB2 mutations [10, 11] and amplification of CDK4[11] and CDK6[10, 11, 26, 27] have been implicated in glioblastoma. This evidence concerns the gene PIK3CA and glioblastoma.